Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
OPKO Health, Inc.
Age
18–65
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
Diagnosis of moderate or severe congenital Hemophilia A or B with or without inhibitors
You may not be if
Diagnosis of any coagulation disorder other than Hemophilia A or B
Receipt of any immunomodulatory therapy within 3 months prior to screening, with the exception of Hepatitis C or HIV therapy
Have had, within one month prior to study drug administration, a major surgical procedure (e.g. orthopedic, abdominal) or have an elective surgery planned within the study period
Use of any anticoagulant for arterial/venous obstructions and/or atrial fibrillation within 7 days prior to first study drug administration
Malignancy within past 5 years (excluding non-melanoma skin cancer)
Clareo Health | A Study of a Long-Acting r-Factor 7a (Factor VIIa) in Adult Men With Hemophilia A or B
